Combining immunotherapy and radiotherapy in hepatocellular carcinoma: the importance of irradiated tumor burden and the possible role of a low dose radiotherapy induction strategy.

Grassberger, Clemens; King, Gentry; Apisarnthanarax, Smith

Grassberger, Clemens; King, Gentry; Apisarnthanarax, Smith.

Afiliación

Grassberger C; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
King G; Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA, USA.
Apisarnthanarax S; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.

Transl Cancer Res ; 12(4): 701-704, 2023 Apr 28.

Article en En | MEDLINE | ID: mdl-37180671

Palabras clave

Hepatocellular carcinoma (HCC); checkpoint inhibition; combination therapy; radiotherapy (RT); tumor burden

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos